Pfizer Overview
Pfizer Target Price
Analysts' 12-month price predictions for PFE.
Share Price
$22.83
Average Target Price
$24.00
5.1% upside
5.1% upside1 analysts in the last 4 months
High: $24 | Low: $24
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-22 | Cantor FitzgeraldCarter Gould | $24 | 5.1% upside |  |
| 2024-12-18 | Truist FinancialRobyn Karnauskas | $32 | 40.2% upside | |
| 2024-10-30 | Goldman SachsChris Shibutani | $33 | 44.5% upside | |
| 2024-10-17 | BernsteinCourtney Breen | $32 | 40.2% upside | |
| 2024-09-25 | BarclaysCarter Gould | $32 | 40.2% upside | |
| 2024-08-07 | DaiwaNarumi Nakagiri | $34 | 48.9% upside | |
| 2024-07-31 | Wells FargoMohit Bansal | $30 | 31.4% upside | |
| 2024-07-31 | Goldman SachsChris Shibutani | $34 | 48.9% upside | |
| 2024-07-30 | GuggenheimVamil Divan | $36 | 57.7% upside | |
| 2024-07-10 | BarclaysCarter Gould | $30 | 31.4% upside | |
| 2024-05-22 | BMO CapitalEvan Seigerman | $36 | 57.7% upside | |
| 2024-02-14 | Cantor FitzgeraldLouise Chen | $45 | 97.1% upside | |
| 2023-12-14 | Morgan StanleyThomas Yeh | $20 |  12.4% downside | |
| 2023-11-27 | Morgan StanleyTerence Flynn | $37 | 62.1% upside | |
| 2023-02-01 | Morgan Stanley | $45 | 97.1% upside | |
| 2023-02-01 | Credit Suisse | $50 | 119% upside | |
| 2023-02-01 | Barclays | $44 | 92.7% upside | |
| 2023-02-01 | Atlantic Equities | $46 | 101.5% upside | |
| 2023-02-01 | Leerink Partners | $48 | 110.2% upside | |
| 2022-12-14 | Morgan Stanley | $53 | 132.2% upside | |
| 2022-12-13 | Goldman SachsChris Shibutani | $60 | 162.8% upside | |
| 2022-11-18 | Credit Suisse | $55 | 140.9% upside | |
| 2022-05-23 | Leerink PartnersDavid Risinger | $55 | 140.9% upside | |
| 2022-05-10 | Wells FargoMohit Bansal | $54.42 | 138.4% upside | |
| 2022-05-09 | Wells FargoMohit Bansal | $55 | 140.9% upside | |
| 2022-05-04 | Morgan Stanley | $52 | 127.8% upside | |
| 2022-05-02 | Mizuho SecuritiesVamil Divan | $55 | 140.9% upside | |
| 2022-04-15 | Cantor FitzgeraldLouise Chen | $75 | 228.5% upside | |
| 2022-04-10 | Morgan StanleyTerrance Flynn | $55 | 140.9% upside | |
| 2022-04-09 | CitigroupAndrew Baum | $57 | 149.7% upside | |
| 2022-03-12 | Bank of America SecuritiesGeoff Meacham | $70 | 206.6% upside | |
| 2022-02-08 | J.P. MorganChris Schott | $57 | 149.7% upside | |
| 2022-02-08 | BarclaysCarter Gould | $54 | 136.5% upside | |
| 2022-02-08 | Goldman SachsChris Shibutani | $50 | 119% upside | |
| 2022-01-15 | BMO CapitalEvan Seigerman | $76 | 232.9% upside | |
| 2022-01-03 | BernsteinAaron Gal | $65 | 184.7% upside | |
| 2021-12-22 | Leerink PartnersGeoff Porges | $56 | 145.3% upside | |
| 2021-12-13 | UBSColin Bristow | $60 | 162.8% upside | |
| 2021-11-11 | Independent ResearchTobias Gottschalt | $54 | 136.5% upside | |
| 2021-11-03 | Wolfe ResearchTim Anderson | $46 | 101.5% upside | |
| 2021-07-29 | RBC CapitalDaniel Busby | $44 | 92.7% upside | |
| 2021-06-01 | Argus ResearchDavid Toung | $55 | 140.9% upside | |